Use of apathogenic vaccinia virus MVA expressing EHV-1 gC as basis of a combined recombinant MVA/DNA vaccination scheme (Q44291817)

1 December 2017

title

Use of apathogenic vaccinia virus MVA expressing EHV-1 gC as basis of a combined recombinant MVA/DNA vaccination scheme (English)

1 reference

1 December 2017

vaccinia virus

1 reference

2

1 reference

1 December 2017

Huemer HP

1

1 reference

1 December 2017

Nowotny N

series ordinal

3

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 January 2000

1 reference

1 December 2017

1 reference

1 December 2017

volume

18

1 reference

1 December 2017

issue

14

1 reference

1 December 2017

page(s)

1320-1326

1 reference

CpG motifs as immune adjuvants

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900413-2

7 January 2021

Differences in the role of glycoprotein C of HSV-1 and HSV-2 in viral binding may contribute to serotype differences in cell tropism

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900413-2

7 January 2021

Glycoprotein C-deficient mutants of two strains of herpes simplex virus type 1 exhibit unaltered adsorption characteristics on polarized or non-polarized cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900413-2

7 January 2021

Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: implications for use as a human vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900413-2

7 January 2021

Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900413-2

7 January 2021

gp13 (EHV-gC): a complement receptor induced by equine herpesviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900413-2

7 January 2021

Studies on glycoprotein 13 (gp13) of equid herpesvirus 1 using affinity-purified gp13, glycoprotein-specific monoclonal antibodies and synthetic peptides in a hamster model

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900413-2

7 January 2021

Evaluation of the thymidine kinase (tk) locus as an insertion site in the highly attenuated vaccinia MVA strain

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900413-2

7 January 2021

Comparison of DNA application methods to reduce BRSV shedding in cattle

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900413-2

7 January 2021

Plasmid DNA vaccination: mechanism of antigen presentation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900413-2

7 January 2021

Immune responses and protective efficacy of recombinant baculovirus-expressed glycoproteins of equine herpesvirus 1 (EHV-1) gB, gC and gD alone or in combinations in BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900413-2

7 January 2021

Protection of pigs against Aujeszky's disease by DNA vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900413-2

7 January 2021

10.1016/S0264-410X(99)00413-2

Identifiers

DOI

1 reference

1 December 2017

1 reference